Opinião1. Global tuberculosis report 2020. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/ bitstream/handle/10665/336069/9789240013131-eng.pdf, accessed 19 February 2021).
2. Uplekar M, Weil D, Lönnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO’s new End TB Strategy. Lancet. 2015;385:1799–801. doi:10.1016/s0140–6736(15)60570–0.
3. The End TB Strategy [website]. Geneva: World Health Organization; 2021 (http://www.who.int/tb/strategy/ en/, accessed 19 February 2021).
4. Political declaration of the UN General Assembly High-Level Meeting on the Fight Against Tuberculosis. New York: United Nations; 2018 (https://www.who.int/tb/unhlmonTBDeclaration.pdf, accessed 19 February 2021).
5. Systematic screening for active tuberculosis: principles and recommendations. Geneva: World Health Organization; 2013 (https://apps.who.int/iris/handle/10665/84971, accessed 19 February 2021).
6. Early detection of tuberculosis: an overview of approaches, guidelines and tools. Geneva: World Health Organization; 2011 (https://apps.who.int/iris/handle/10665/70824, accessed 19 February 2021).
7. WHO operational handbook on tuberculosis. Module 2: screening – systematic screening for tuberculosis disease. Geneva: World Health Organization; 2021.
8. Consolidated guidelines on HIV testing services: 2019. Geneva: World Health Organization; 2020 (https://apps.who.int/iris/bitstream/handle/10665/94836/9789241506410_eng.pdf, accessed 19 February 2021).
9. Guideline: Nutritional care and support for patients with tuberculosis. Geneva: World Health Organization; 2013 (https://apps.who.int/iris/bitstream/handle/10665/94836/9789241506410_eng.pdf, accessed 19 February 2021).
10. Ethics guidance for the implementation of the End TB Strategy. Geneva: World Health Organization; 2017 (https://apps.who.int/iris/handle/10665/254820, accessed 19 February 2021).
11. Resolution WHA61.17. Health of migrants. In: Sixty-first World Health Assembly, Geneva, 19–24 May 2008. Resolutions and decisions; annexes. Geneva: World Health Organization; 2008 (https://www.who.int/ migrants/publications/A61-17.pdf, accessed 19 February 2021).
12. Kass NE. An ethics framework for public health. Am J Public Health. 2001;91:1776–82. doi:10.2105/ ajph.91.11.1776.
13. Marks GB, Nguyen NV, Nguyen PTB, Nguyen TA, Nguyen HB, Tran KH, et al. Community-wide screening for tuberculosis in a high-prevalence setting. N Engl J Med. 2019;381:1347–57. doi:10.1056/NEJMoa1902129.
14. Liu K, Peng Y, Zhou Q, Cheng J, Yu H, Tang L, et al. Assessment of active tuberculosis findings in the eastern area of China: a 3-year sequential screening study. Int J Infect Dis. 2019;88:34–40. doi:10.1016/j. ijid.2019.07.029.
15. Ayles H, Muyoyeta M, Du Toit E, Schaap A, Floyd S, Simwinga M, et al. Effect of household and community interventions on the burden of tuberculosis in southern Africa: The ZAMSTAR community-randomised trial. Lancet. 2013;382:1183–94. doi:10.1016/s0140–6736(13)61131–9.
16. Closing the gap in a generation: health equity through action on the social determinants of health. Final report of the Commission on Social Determinants of Health. Geneva: World Health Organization; 2008 (https://apps.who.int/iris/handle/10665/43943, accessed 19 February 2021).
17. Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JD. The social determinants of tuberculosis: from evidence to action. Am J Public Health. 2011;101:654–62. doi:10.2105/ajph.2010.199505.
18. Connolly MA, Gayer M, Ottmani S, editors.Tuberculosis care and control in refugee and displaced populations: an interagency field manual, second edition Geneva: World Health Organization; 2007 (https://apps.who. int/iris/handle/10665/43661, accessed 19 February 2021).
19. Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. Geneva: World Health Organization; 2011 (https://apps.who.int/iris/ handle/10665/44472, accessed 19 February 2021).
20. WHO consolidated guidelines on tuberculosis. Module 1: prevention – tuberculosis preventive treatment. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/who-consolidatedguidelines-on-tuberculosis-module-1-prevention-tuberculosis-preventive-treatment, accessed 19 February 2021).
21. Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middleincome countries. Geneva: World Health Organization; 2012 (https://apps.who.int/iris/handle/10665/77741, accessed February 19, 2021).
22. Fox GJ, Nhung NV, Marks GB. Household-contact investigation for detection of tuberculosis in Vietnam. N Engl J Med. 2018;378:2140–1. doi:10.1056/NEJMc1804977.
23. Martinez L, Cords O, Horsburgh CR, Andrews JR. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis. Lancet. 2020;395:973–84. doi:10.1016/ s0140–6736(20)30166–5.
24. Baussano I, Williams BG, Nunn P, Beggiato M, Fedeli U, Scano F. Tuberculosis incidence in prisons: a systematic review. PlOS Med. 2010;7:e1000381. doi:10.1371/journal.pmed.1000381.
25. Paião DS, Lemos EF, Carbone AD, Sgarbi RV, Junior AL, da Silva FM, et al. Impact of mass-screening on tuberculosis incidence in a prospective cohort of Brazilian prisoners. BMC Infect Dis. 2016;16:533. doi:10.1186/s12879–016–1868–5.
26. Sanchez A, Massari V, Gerhardt G, Espinola AB, Siriwardana M, Camacho LA, et al. X ray screening at entry and systematic screening for the control of tuberculosis in a highly endemic prison. BMC Public Health. 2013;13:983. doi:10.1186/1471–2458–13–983.
27. Tsegaye Sahle E, Blumenthal J, Jain S, Sun S, Young J, Manyazewal T et al. Bacteriologically-confirmed pulmonary tuberculosis in an Ethiopian prison: prevalence from screening of entrant and resident prisoners. PLOS ONE. 2019;14:e0226160. doi:10.1371/journal.pone.0226160.
28. Adane K, Spigt M, Dinant GJ. Tuberculosis treatment outcome and predictors in northern Ethiopian prisons: a five-year retrospective analysis. BMC Pulm Med. 2018;18:37. doi: 10.1186/s12890–018–0600–1.
29. Guidelines for the control of tuberculosis in prisons. Geneva: World Health Organization; 1998 (https:// www.who.int/tb/publications/control-prisons-guidelines/en/, accessed 19 February 2021).
30. Barboza CE, Winter DH, Seiscento M, Santos Ude P, Terra Filho M. Tuberculosis and silicosis: epidemiology, diagnosis and chemoprophylaxis. J Bras Pneumol. 2008;34:959–66. doi:10.1590/s1806–37132008001100012.
31. Corbett EL, Churchyard GJ, Clayton TC, Williams BG, Mulder D, Hayes RJ, et al. HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners. AIDS. 2000;14:2759–68. doi:10.1097/00002030–200012010–00016.
32. Churchyard GJ, Ehrlich R, teWaterNaude JM, Pemba L, Dekker K, Vermeijs M, et al. Silicosis prevalence and exposure-response relations in South African goldminers. Occup Environ Med. 2004;61:811–6. doi:10.1136/ oem.2003.010967.
33. Churchyard GJ, Kleinschmidt I, Corbett EL, Murray J, Smit J, De Cock KM. Factors associated with an increased case–fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000;4:705–12.
34. Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28–106.
35. Meijer J, Barnett GD, Kubík A, Stýblo K. Identification des sources d’infection [Identification of sources of infection]. Bull Int Union Tuberc. 1971;45:5–54.
36. Okada K, Onozaki I, Yamada N, Yoshiyama T, Miura T, Saint S, et al. Epidemiological impact of mass tuberculosis screening: a 2-year follow-up after a national prevalence survey. Int J Tuberc Lung Dis. 2012;16:1619–24. doi:10.5588/ijtld.12.0201.
37. Gao L, Li X, Liu J, Wang X, Lu W, Bai L, et al. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis. 2017;17:1053–61. doi:10.1016/s1473–3099(17)30402–4.
38. Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop Med Int Health. 2018;23:1058–70. doi:10.1111/tmi.13133.
39. Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLOS ONE. 2017;12:e0187967. doi:10.1371/journal. pone.0187967.
40. Harries AD, Kumar AM, Satyanarayana S, Lin Y, Zachariah R, Lönnroth K, et al. Addressing diabetes mellitus as part of the strategy for ending TB. Trans R Soc Trop Med Hyg. 2016;110:173–9. doi:10.1093/trstmh/trv111.
41. Baker MA, Harries AD, Jeon CY, Hart JE, Kapur A, Lönnroth K, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9:81. doi:10.1186/1741–7015–9-81.
42. Zignol M, Wright A, Jaramillo E, Nunn P, Raviglione MC. Patients with previously treated tuberculosis no longer neglected. Clin Infect Dis. 2007;44:61–4. doi:10.1086/509328.
43. Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der Stuyft P. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis. 2003;3:282–7. doi:10.1016/s1473–3099(03)00607–8.
44. Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005;171:1430–5. doi:10.1164/rccm.200409–1200OC.
45. Osman M, Welte A, Dunbar R, Brown R, Hoddinott G, Hesseling AC, et al. Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: a pilot study. Int J Infect Dis. 2019;85:57–63. doi:10.1016/j. ijid.2019.05.024.
46. Inghammar M, Ekbom A, Engström G, Ljungberg B, Romanus V, Löfdahl CG, et al. COPD and the risk of tuberculosis–a population-based cohort study. PLOS ONE. 2010;5:e10138. doi:10.1371/journal. pone.0010138.
47. Lee CH, Lee MC, Shu CC, Lim CS, Wang JY, Lee LN et al. Risk factors for pulmonary tuberculosis in patients with chronic obstructive airway disease in Taiwan: a nationwide cohort study. BMC Infect Dis. 2013;13:194. doi:10.1186/1471-2334-13-194.
48. Jayes L, Haslam PL, Gratziou CG, Powell P, Britton J, Vardavas C, et al. SmokeHaz: systematic reviews and meta-analyses of the effects of smoking on respiratory health. Chest. 2016;150:164–79. doi:10.1016/j. chest.2016.03.060.
49. Lin HH, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis. PLOS Med. 2007;4:e20. doi:10.1371/journal.pmed.0040020.
50. Wang MG, Huang WW, Wang Y, Zhang YX, Zhang MM, Wu SQ, et al. Association between tobacco smoking and drug-resistant tuberculosis. Infect Drug Resist. 2018;11:873–87. doi:10.2147/idr.s164596.
51. Alavi-Naini R, Sharifi-Mood B, Metanat M. Association between tuberculosis and smoking. Int J High Risk Behav Addict. 2012;1:71–4. doi:10.5812/ijhrba.5215.
52. Imtiaz S, Shield KD, Roerecke M, Samokhvalov AV, Lönnroth K, Rehm J. Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease. Eur Respir J. 2017;50:1700216. doi:10.1183/13993003.00216–2017.
53. Simou E, Britton J, Leonardi-Bee J. Alcohol consumption and risk of tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis. 2018;22:1277–85. doi:10.5588/ijtld.18.0092.
54. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lönnroth K, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health. 2009;9:450. doi:10.1186/1471–2458–9-450.
55. Deiss RG, Rodwell TC, Garfein RS. Tuberculosis and illicit drug use: review and update. Clin Infect Dis. 2009;48:72–82. doi:10.1086/594126.
56. Getahun H, Gunneberg C, Sculier D, Verster A, Raviglione M. Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services. Curr Opin HIV AIDS. 2012;7:345–53. doi:10.1097/COH.0b013e328354bd44.
57. Silva DR, Muñoz-Torrico M, Duarte R, Galvão T, Bonini EH, Arbex FF, et al. Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs. J Bras Pneumol. 2018;44:145–52. doi:10.1590/ s1806–37562017000000443.
58. Lönnroth K, Williams BG, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol. 2010;39:149–55. doi:10.1093/ije/dyp308.
59. Cegielski JP, McMurray DN. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis. 2004;8:286–98.
60. Jonsson J, Kühlmann-Berenzon S, Berggren I, Bruchfeld J. Increased risk of active tuberculosis during pregnancy and postpartum: a register-based cohort study in Sweden. Eur Respir J. 2020;55:1901886. doi:10.1183/13993003.01886–2019.
61. Sugarman J, Colvin C, Moran AC, Oxlade O. Tuberculosis in pregnancy: an estimate of the global burden of disease. Lancet Glob Health. 2014;2:e710–6. doi:10.1016/s2214–109x(14)70330–4. doi:10.1016/ S2214–109X(14)70330–4.
62. Loto OM, Awowole I. Tuberculosis in pregnancy: a review. J Pregnancy. 2012;2012:379271. doi:10.1155/2012/379271.
63. Muñoz P, Rodríguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis. 2005;40:581–7. doi:10.1086/427692.
64. Moran E, Baharani J, Dedicoat M, Robinson E, Smith G, Bhomra P, et al. Risk factors associated with the development of active tuberculosis among patients with advanced chronic kidney disease. J Infect. 2018;77:291–5. doi:10.1016/j.jinf.2018.06.003.
65. Moore DA, Lightstone L, Javid B, Friedland JS. High rates of tuberculosis in end-stage renal failure: the impact of international migration. Emerg Infect Dis. 2002;8:77–8. doi:10.3201/eid0801.010017.
66. Uden L, Barber E, Ford N, Cooke GS. Risk of tuberculosis infection and disease for health care workers: an updated meta-analysis. Open Forum Infect Dis. 2017;4:ofx137. doi:10.1093/ofid/ofx137.
67. High-priority target product profiles for new tuberculosis diagnostics: report of a consensus meeting, 28–29 April 2014, Geneva, Switzerland. Geneva: World Health Organization; 2014 (https://apps.who.int/ iris/handle/10665/135617, accessed 19 February 2021).
68. Chest radiography in tuberculosis detection: summary of current who recommendations and guidance on programmatic approaches. Geneva: World Health Organization; 2016 (https://apps.who.int/iris/ handle/10665/252424, accessed 19 February 2021).
69. WHO consolidated guidelines on tuberculosis. Module 3: diagnosis – rapid diagnostics for tuberculosis detection. Geneva: World Health Organization; 2020 (https://www.who.int/publications/i/item/ who-consolidated-guidelines-on-tuberculosis-module-3-diagnosis---rapid-diagnostics-for-tuberculosisdetection, accessed 19 February 2021).
70. Piccazzo R, Paparo F, Garlaschi G. Diagnostic accuracy of chest radiography for the diagnosis of tuberculosis (TB) and its role in the detection of latent TB infection: a systematic review. J Rheumatol Suppl. 2014;91:32– 40. doi:10.3899/jrheum.140100.
71. Van’t Hoog AH, Langendam MW, Mitchell E, Cobelens FG, Sinclair D, Leefland MMG, Lonnroth K. A systematic review of the sensitivity and specificity of symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative persons and persons with unknown HIV status. Geneva: World health Organization; 2013 (https://www.who.int/tb/Review2Accuracyofscreeningtests.pdf, accessed 19 February 2021).
72. Pinto LM, Pai M, Dheda K, Schwartzman K, Menzies D, Steingart KR. Scoring systems using chest radiographic features for the diagnosis of pulmonary tuberculosis in adults: a systematic review. Eur Respir J. 2013;42:480– 94. doi:10.1183/09031936.00107412.
73. Ahmad Khan F, Pande T, Tessema B, Song R, Benedetti A, Pai M et al. Computer-aided reading of tuberculosis chest radiography: moving the research agenda forward to inform policy. Eur Respir J. 2017;50:1700953. doi:10.1183/13993003.00953-2017.
74. Nathavitharana RR, Yoon C, Macpherson P, Dowdy DW, Cattamanchi A, Somoskovi A et al. Guidance for studies evaluating the accuracy of tuberculosis triage tests. J Infect Dis. 2019;220(Suppl. 3):S116–25. doi:10.1093/infdis/jiz243.
75. Gupta RK, Lucas SB, Fielding KL, Lawn SD. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis. AIDS. 2015;29:1987– 2002. doi:10.1097/QAD.0000000000000802.
76. Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, et al. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLOS Med. 2011;8:e1000391. doi:10.1371/journal. pmed.1000391.
77. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization; 2018 (https://apps.who.int/iris/handle/10665/260233, accessed 19 February 2021).
78. LaCourse SM, Cranmer LM, Matemo D, Kinuthia J, Richardson BA, John-Stewart G, et al. Tuberculosis case finding in HIV-infected pregnant women in Kenya reveals poor performance of symptom screening and rapid diagnostic tests. J Acquir Immune Defic Syndr. 2016;71:219–27. doi:10.1097/QAI.0000000000000826.
79. Churchyard G, Cardenas V, Chihota V, Mngadi K, Sebe M, Brumskine WL, et al. Effectiveness of 3HP annually vs once for HIV-positive people: the WHIP3TB trial [website]. San Francisco (CA): IAS-USA; 2020 (https://www.croiconference.org/abstract/effectiveness-of-3hp-annually-vs-once-for-hiv-positive-peoplethe-whip3tb-trial/, accessed 19 February 2021).
80. Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE. The global burden of tuberculosis mortality in children: a mathematical modelling study. Lancet Glob Health. 2017;5:e898–906. doi:10.1016/ s2214-109x(17)30289-9.
81. Tuberculosis prevalence surveys: a handbook. Geneva: World Health Organization; 2011 (https://apps.who. int/iris/handle/10665/44481, accessed 4 March 2021).